Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences Stock Forecast

Stock Price Forecast

The 9 analysts that cover Arcus Biosciences stock have a consensus rating of "Buy" and an average price target of $28.22, which forecasts a 48.60% increase in the stock price over the next year. The lowest target is $14 and the highest is $56.

Price Target: $28.22 (+48.60%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$14	$28.22	$26	$56
Change	-26.28%	+48.60%	+36.91%	+194.89%

Analyst Ratings

The average analyst rating for Arcus Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	1	3	3	3	4	4
Buy	5	3	3	3	2	1
Hold	2	2	2	2	3	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Eva Fortea Verdejo Wells Fargo	Wells Fargo	Buy → Hold Downgrades $30 → $23	Buy → Hold	Downgrades	$30 → $23	+21.12%	Feb 12, 2026
Richard Law Goldman Sachs	Goldman Sachs	Hold → Strong Buy Upgrades $16 → $28	Hold → Strong Buy	Upgrades	$16 → $28	+47.45%	Jan 13, 2026
Terence Flynn Morgan Stanley	Morgan Stanley	Buy → Hold Downgrades $23 → $20	Buy → Hold	Downgrades	$23 → $20	+5.32%	Jan 8, 2026
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $28 → $32	Strong Buy	Maintains	$28 → $32	+68.51%	Dec 12, 2025
Jason Zemansky B of A Securities	B of A Securities	Hold Maintains $17 → $26	Hold	Maintains	$17 → $26	+36.91%	Nov 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

251.47M

Decreased by -2.53%

from 258.00M

Revenue Next Year

122.68M

Decreased by -51.21%

from 251.47M

EPS This Year

-3.50

from -3.14

EPS Next Year

-4.01

from -3.50

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	78.00M	383.00M	112.00M	117.00M	258.00M	251.47M	122.68M
Revenue Growth	420.00%	391.03%	-70.76%	4.46%	120.51%	-2.53%	-51.21%
EPS	-2.24	0.71	-3.71	-4.15	-3.14	-3.50	-4.01
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	352.7M	253.0M
Avg	251.5M	122.7M
Low	224.4M	6.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	36.7%	0.6%
Avg	-2.5%	-51.2%
Low	-13.0%	-97.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-2.90	-3.33
Avg	-3.50	-4.01
Low	-3.76	-4.75

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.